|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crowell JA: The chemopreventive agent
development research program in the Division of Cancer Prevention
of the US National Cancer Institute: an overview. Eur J Cancer.
41:1889–1910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cragg GM, Newman DJ and Snader KM: Natural
products in drug discovery and development. J Natl Prod. 60:52–60.
1997. View Article : Google Scholar
|
|
5
|
Harvey AL: Natural products in drug
discovery. Drug Discov Today. 13:894–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu LX, Gu XF, Zhu YC and Zhu YZ:
Protective effects of novel single compound, hirsutine on hypoxic
neonatal rat cardiomyocytes. Eur J Pharmacol. 650:290–297. 2011.
View Article : Google Scholar
|
|
7
|
Horie S, Yano S, Aimi N, Sakai S and
Watanabe K: Effects of hirsutine, an antihypertensive indole
alkaloid from Uncaria rhynchophylla, on intracellular calcium in
rat thoracic aorta. Life Sci. 50:491–498. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lou C, Takahashi K, Irimura T, Saiki I and
Hayakawa Y: Identification of hirsutine as an anti-metastatic
phytochemical by targeting NF-κB activation. Int J Oncol.
45:2085–2091. 2014.PubMed/NCBI
|
|
9
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saddoughi SA, Song P and Ogretmen B: Roles
of bioactive sphingolipids in cancer biology and therapeutics.
Subcell Biochem. 49:413–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu H, Huang M, Yang F, et al: R16, a
novel amonafide analogue, induces apoptosis and G2-M arrest via
poisoning topoisomerase II. Mol Cancer Ther. 6:484–495. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai Y, Lu J, Miao Z, Lin L and Ding J:
Reactive oxygen species contribute to cell killing and
P-glycoprotein downregulation by salvicine in multidrug resistant
K562/A02 cells. Cancer Biol Ther. 6:1794–1799. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cai B, Lyu H, Huang J, et al: Combination
of bendamustine and entinostat synergistically inhibits
proliferation of multiple myeloma cells via induction of apoptosis
and DNA damage response. Cancer Lett. 335:343–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kudoh T, Kimura J, Lu ZG, Miki Y and
Yoshida K: D4S234E, a novel p53-responsive gene, induces apoptosis
in response to DNA damage. Exp Cell Res. 316:2849–2858. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rudolf E, Kralova V, Rudolf K and John S:
The role of p38 in irinotecan-induced DNA damage and apoptosis of
colon cancer cells. Mutat Res. 741–742:27–34. 2013. View Article : Google Scholar
|
|
16
|
Norbury CJ and Zhivotovsky B: DNA
damage-induced apoptosis. Oncogene. 23:2797–2808. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ljungman M: The DNA damage response -
repair or despair? Environ Mol Mutagen. 51:879–889. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roos WP and Kaina B: DNA damage-induced
cell death by apoptosis. Trends Mol Med. 12:440–450. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mah LJ, El-Osta A and Karagiannis TC:
gammaH2AX: a sensitive molecular marker of DNA damage and repair.
Leukemia. 24:679–686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Valdiglesias V, Giunta S, Fenech M, Neri M
and Bonassi S: γH2AX as a marker of DNA double strand breaks and
genomic instability in human population studies. Mutat Res.
753:24–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Redon CE, Nakamura AJ, Zhang YW, et al:
Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic
biomarkers. Clin Cancer Res. 16:4532–4542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ivashkevich AN, Martin OA, Smith AJ, et
al: γH2AX foci as a measure of DNA damage: a computational approach
to automatic analysis. Mutat Res. 711:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao G and Fu J: NF-κB and cancer: a
paradigm of Yin-Yang. Am J Cancer Res. 1:192–221. 2011.
|
|
24
|
Basseres DS and Baldwin AS: Nuclear
factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic
initiation and progression. Oncogene. 25:6817–6830. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bours V, Bonizzi G, Bentires-Alj M, et al:
NF-kappaB activation in response to toxical and therapeutical
agents: role in inflammation and cancer treatment. Toxicology.
153:27–38. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang CY, Fong YC, Lee CY, et al: CCL5
increases lung cancer migration via PI3K, Akt and NF-kappaB
pathways. Biochem Pharmacol. 77:794–803. 2009. View Article : Google Scholar
|
|
27
|
Nottingham LK, Yan CH, Yang X, et al:
Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce
EGFR/AP1 signaling to promote survival and migration of head and
neck cancer. Oncogene. 33:1135–1147. 2014. View Article : Google Scholar :
|
|
28
|
Zhang W, Tan W, Wu X, et al: A NIK-IKKα
module expands ErbB2-induced tumor-initiating cells by stimulating
nuclear export of p27/Kip1. Cancer Cell. 23:647–659. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ryan KM, Ernst MK, Rice NR and Vousden KH:
Role of NF-kappaB in p53-mediated programmed cell death. Nature.
404:892–897. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kaltschmidt B, Kaltschmidt C, Hofmann TG,
Hehner SP, Droge W and Schmitz ML: The pro- or anti-apoptotic
function of NF-kappaB is determined by the nature of the apoptotic
stimulus. Eur J Biochem. 267:3828–3835. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Janssens S and Tschopp J: Signals from
within: the DNA-damage-induced NF-kappaB response. Cell Death
Differ. 13:773–784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volcic M, Karl S, Baumann B, et al: NF-κB
regulates DNA double-strand break repair in conjunction with
BRCA1-CtIP complexes. Nucleic Acids Res. 40:181–195. 2012.
View Article : Google Scholar :
|
|
33
|
Kandel ES, Skeen J, Majewski N, et al:
Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle
checkpoint induced by DNA damage. Mol Cell Biol. 22:7831–7841.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Henry MK, Lynch JT, Eapen AK and Quelle
FW: DNA damage-induced cell-cycle arrest of hematopoietic cells is
overridden by activation of the PI-3 kinase/Akt signaling pathway.
Blood. 98:834–841. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Toulany M, Kasten-Pisula U, Brammer I, et
al: Blockage of epidermal growth factor
receptor-phosphatidylinositol 3-kinase-AKT signaling increases
radiosensitivity of K-RAS mutated human tumor cells in vitro by
affecting DNA repair. Clin Cancer Res. 12:4119–4126. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Toulany M, Kehlbach R, Florczak U, et al:
Targeting of AKT1 enhances radiation toxicity of human tumor cells
by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
Mol Cancer Ther. 7:1772–1781. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Toulany M, Kehlbach R, Rodermann HP and
Mozdarani H: Radiocontrast media affect radiation-induced DNA
damage repair in vitro and in vivo by affecting Akt signalling.
Radiother Oncol. 94:110–116. 2010. View Article : Google Scholar
|
|
38
|
Sanchez-Prieto R, Rojas JM, Taya Y and
Gutkind JS: A role for the p38 mitogen-activated protein kinase
pathway in the transcriptional activation of p53 on genotoxic
stress by chemotherapeutic agents. Cancer Res. 60:2464–2472.
2000.PubMed/NCBI
|
|
39
|
Lu C, Shi Y, Wang Z, et al: Serum
starvation induces H2AX phosphorylation to regulate apoptosis via
p38 MAPK pathway. FEBS Lett. 582:2703–2708. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bulavin DV, Saito S, Hollander MC, et al:
Phosphorylation of human p53 by p38 kinase coordinates N-terminal
phosphorylation and apoptosis in response to UV radiation. EMBO J.
18:6845–6854. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Madson JG, Lynch DT, Svoboda J, et al:
Erbb2 suppresses DNA damage-induced checkpoint activation and
UV-induced mouse skin tumorigenesis. Am J Pathol. 174:2357–2366.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Boone JJ, Bhosle J, Tilby MJ, Hartley JA
and Hochhauser D: Involvement of the HER2 pathway in repair of DNA
damage produced by chemotherapeutic agents. Mol Cancer Ther.
8:3015–3023. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wasserman E, Sutherland W and Cvitkovic E:
Irinotecan plus oxaliplatin: a promising combination for advanced
colorectal cancer. Clin Colorectal Cancer. 1:149–153. 2001.
View Article : Google Scholar
|
|
44
|
Ikeda M, Kurebayashi J, Sonoo H, et al:
Evaluation of irinotecan hydrochloride (CPT-11) and trastuzumab
combination therapy as salvage treatment in patients with HER2
overexpressing metastatic breast cancer. Gan To Kagaku Ryoho.
36:773–777. 2009.(In Japanese). PubMed/NCBI
|
|
45
|
Anders C, Deal AM, Abramson V, et al:
TBCRC 018: phase II study of iniparib in combination with
irinotecan to treat progressive triple negative breast cancer brain
metastases. Breast Cancer Res Treat. 146:557–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen AY and Liu LF: DNA topoisomerases:
essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol.
34:191–218. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pommier Y: Eukaryotic DNA topoisomerase I:
genome gatekeeper and its intruders, camptothecins. Semin Oncol.
23:3–10. 1996.PubMed/NCBI
|
|
48
|
Neve RM, Chin K, Fridlyand J, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Holliday DL and Speirs V: Choosing the
right cell line for breast cancer research. Breast Cancer Res.
13:2152011. View
Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hermanto U, Zong CS and Wang LH:
ErbB2-overexpressing human mammary carcinoma cells display an
increased requirement for the phosphatidylinositol 3-kinase
signaling pathway in anchorage-independent growth. Oncogene.
20:7551–7562. 2001. View Article : Google Scholar : PubMed/NCBI
|
